What are the stocks related to monkeypox

Symbols

8/19/2024 03:02am

Aime

Based on your interest in stocks related to monkeypox, we have identified 11 relevant stocks. The details are as follows¹:

theme include monkeypox(11)

last-price	last-change%	Theme	Theme Description	Inclusion Reason
1.02	22.16%	Monkeypox	Monkeypox is an infectious viral disease that can occur in humans and some other animals.The virus which causes monkeypox originates from the same ‘family’ as smallpox, Smallpox vaccine thought to prevent monkeypox infection in humans. However, monkeypox is significantly less severe than smallpox. According to the WHO, Monkeypox's symptoms include fever, swollen lymph nodes, and a rash that forms blisters and then crusts over.The time from exposure to onset of symptoms ranges from five to twenty-one days. In late-July 2022, the World Health Organization declared the worldwide outbreak of monkeypox a public health emergency. The worldwide number of cases has risen to 21,099 as of July 29.	on June 04, 2021 Chimerix introducing TEMBEXA the first antiviral to be approved for the treatment of smallpox in all age groups, including infants, and for patients who have difficulty swallowing.
1.37	10.08%	Monkeypox	Monkeypox is an infectious viral disease that can occur in humans and some other animals.The virus which causes monkeypox originates from the same ‘family’ as smallpox, Smallpox vaccine thought to prevent monkeypox infection in humans. However, monkeypox is significantly less severe than smallpox. According to the WHO, Monkeypox's symptoms include fever, swollen lymph nodes, and a rash that forms blisters and then crusts over.The time from exposure to onset of symptoms ranges from five to twenty-one days. In late-July 2022, the World Health Organization declared the worldwide outbreak of monkeypox a public health emergency. The worldwide number of cases has risen to 21,099 as of July 29.	Co-Diagnostics is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. On May 26 2022, Co-Diagnostics announced it has completed the principal design work of a PCR test for the monkeypox virus currently exhibiting a multi-country outbreak.
10.74	24.02%	Monkeypox	Monkeypox is an infectious viral disease that can occur in humans and some other animals.The virus which causes monkeypox originates from the same ‘family’ as smallpox, Smallpox vaccine thought to prevent monkeypox infection in humans. However, monkeypox is significantly less severe than smallpox. According to the WHO, Monkeypox's symptoms include fever, swollen lymph nodes, and a rash that forms blisters and then crusts over.The time from exposure to onset of symptoms ranges from five to twenty-one days. In late-July 2022, the World Health Organization declared the worldwide outbreak of monkeypox a public health emergency. The worldwide number of cases has risen to 21,099 as of July 29.	Emergent BioSolutions is a global specialty biopharmaceutical company offering specialized products to health care providers and governments to combat emerging public health threats. Its ACAM2000 Smallpox Vaccine was approved by the U.S. FDA on May 2, 2007, it replaced Dryvax for smallpox vaccinations in February 2008. The U.S. Department of Health and Human Services awarded a contract to Emergent in September 2019 valued at approximately $2 billion over ten years for the continued supply of ACAM2000 into the U.S. Strategic National Stockpile.
73.78	-0.75%	Monkeypox	Monkeypox is an infectious viral disease that can occur in humans and some other animals.The virus which causes monkeypox originates from the same ‘family’ as smallpox, Smallpox vaccine thought to prevent monkeypox infection in humans. However, monkeypox is significantly less severe than smallpox. According to the WHO, Monkeypox's symptoms include fever, swollen lymph nodes, and a rash that forms blisters and then crusts over.The time from exposure to onset of symptoms ranges from five to twenty-one days. In late-July 2022, the World Health Organization declared the worldwide outbreak of monkeypox a public health emergency. The worldwide number of cases has risen to 21,099 as of July 29.	In Aug 2022, Gilead announced will provide up to $5 million in global grant funding to help support three areas of focus: a public education and vaccine hesitancy communications campaign, a public policy response and a global outbreak emergency fund.In addition, Cidofovir (Vistide) is one of core product of Gilead Sciences, according to the NIH, it can be used to treat and help patients with smallpox and monkeypox infections.
7.06	110.75%	Monkeypox	Monkeypox is an infectious viral disease that can occur in humans and some other animals.The virus which causes monkeypox originates from the same ‘family’ as smallpox, Smallpox vaccine thought to prevent monkeypox infection in humans. However, monkeypox is significantly less severe than smallpox. According to the WHO, Monkeypox's symptoms include fever, swollen lymph nodes, and a rash that forms blisters and then crusts over.The time from exposure to onset of symptoms ranges from five to twenty-one days. In late-July 2022, the World Health Organization declared the worldwide outbreak of monkeypox a public health emergency. The worldwide number of cases has risen to 21,099 as of July 29.	On Aug 03 2022 GeoVax Lab announced the evaluation is underway related to GEO-CM04S1 and the prevention of Monkeypox. It is anticipated that the results will demonstrate successful protection, validating that GEO-CM04S1 is protective against both COVID-19 and Monkeypox. GeoVax also anticipates validating its hemorrhagic fever virus vaccines as protective against Monkeypox, potentially providing unique vaccines preventing both hemorrhagic fever virus and Monkeypox virus in a single vaccine.
7.83	0.38%	Monkeypox	Monkeypox is an infectious viral disease that can occur in humans and some other animals.The virus which causes monkeypox originates from the same ‘family’ as smallpox, Smallpox vaccine thought to prevent monkeypox infection in humans. However, monkeypox is significantly less severe than smallpox. According to the WHO, Monkeypox's symptoms include fever, swollen lymph nodes, and a rash that forms blisters and then crusts over.The time from exposure to onset of symptoms ranges from five to twenty-one days. In late-July 2022, the World Health Organization declared the worldwide outbreak of monkeypox a public health emergency. The worldwide number of cases has risen to 21,099 as of July 29.	Inovio Pharmaceuticals is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. Early as 2010, Inovio Pharmaceuticals announced its DNA vaccine demonstrated strong antibody-based immune responses, it make 100% protection of non-human primates against a highly pathogenic monkeypox challenge after vaccination with its smallpox DNA vaccine.
86.84	0.25%	Monkeypox	Monkeypox is an infectious viral disease that can occur in humans and some other animals.The virus which causes monkeypox originates from the same ‘family’ as smallpox, Smallpox vaccine thought to prevent monkeypox infection in humans. However, monkeypox is significantly less severe than smallpox. According to the WHO, Monkeypox's symptoms include fever, swollen lymph nodes, and a rash that forms blisters and then crusts over.The time from exposure to onset of symptoms ranges from five to twenty-one days. In late-July 2022, the World Health Organization declared the worldwide outbreak of monkeypox a public health emergency. The worldwide number of cases has risen to 21,099 as of July 29.	Executives from Moderna said on Aug 3 2022 they have initiated a research program to consider whether the company could create a monkeypox vaccine with mRNA technology.
10.49	9.04%	Monkeypox	Monkeypox is an infectious viral disease that can occur in humans and some other animals.The virus which causes monkeypox originates from the same ‘family’ as smallpox, Smallpox vaccine thought to prevent monkeypox infection in humans. However, monkeypox is significantly less severe than smallpox. According to the WHO, Monkeypox's symptoms include fever, swollen lymph nodes, and a rash that forms blisters and then crusts over.The time from exposure to onset of symptoms ranges from five to twenty-one days. In late-July 2022, the World Health Organization declared the worldwide outbreak of monkeypox a public health emergency. The worldwide number of cases has risen to 21,099 as of July 29.	SIGA Technologies develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. In 2021, SIGA submitted an intravenous version of TPOXX to the FDA for approval, which was approved in May 2022 TPOXX is for the treatment of human smallpox disease caused by Variola virus. On Aug 6 2022 SIGA Technologies announced its Monkeypox drug to start human testing in September.
0.45	-2.10%	Monkeypox	Monkeypox is an infectious viral disease that can occur in humans and some other animals.The virus which causes monkeypox originates from the same ‘family’ as smallpox, Smallpox vaccine thought to prevent monkeypox infection in humans. However, monkeypox is significantly less severe than smallpox. According to the WHO, Monkeypox's symptoms include fever, swollen lymph nodes, and a rash that forms blisters and then crusts over.The time from exposure to onset of symptoms ranges from five to twenty-one days. In late-July 2022, the World Health Organization declared the worldwide outbreak of monkeypox a public health emergency. The worldwide number of cases has risen to 21,099 as of July 29.	Tonix Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics to treat and prevent human disease and alleviate suffering. On 28 July 2022, Tonix Pharmaceuticals announces collaboration with Kenya Medical Research institute to develop TNX-801 in Kenya as a vaccine for the prevention of Monkeypox and Smallpox Infection
3.74	5.20%	Monkeypox	Monkeypox is an infectious viral disease that can occur in humans and some other animals.The virus which causes monkeypox originates from the same ‘family’ as smallpox, Smallpox vaccine thought to prevent monkeypox infection in humans. However, monkeypox is significantly less severe than smallpox. According to the WHO, Monkeypox's symptoms include fever, swollen lymph nodes, and a rash that forms blisters and then crusts over.The time from exposure to onset of symptoms ranges from five to twenty-one days. In late-July 2022, the World Health Organization declared the worldwide outbreak of monkeypox a public health emergency. The worldwide number of cases has risen to 21,099 as of July 29.	T2 Biosystems is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of patient sample types, including whole blood, plasma, serum, saliva, sputum and urine. In Aug 2022 T2 Biosystems announced plans to explore the potential to develop a rapid molecular diagnostic test for detection of the monkeypox virus, including technical and commercial feasibility.

Ticker
CMRXChimerix
CODXCo-diagnostics
EBSEmergent
GILDGilead Sciences
GOVXGeoVax Labs
INOInovio Pharmaceuticals
MRNAModerna
SIGASIGA Technologies
TNXPTonix
TTOOT2 Biosystems

View 11 results more

Source:

1. Theme is Monkeypox